Commonwealth Equity Services’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,500
Closed -$28.9K 4527
2026
Q1
$28.9K Sell
16,500
-150
-0.9% -$273 ﹤0.01% 4236
2025
Q4
$39.1K Buy
+16,650
New +$32K ﹤0.01% 4204
2017
Q3
Hold
0
-$89K 2595
2017
Q2
Hold
0
2386
2017
Q1
Hold
0
2274
2016
Q4
Hold
0
2313
2016
Q3
Hold
0
2244
2016
Q2
Hold
0
2234
2016
Q1
Hold
0
2191
2015
Q4
Hold
0
2165
2015
Q3
Hold
0
2104
2015
Q2
Hold
0
2035
2015
Q1
Hold
0
2028
2014
Q4
Hold
0
1934
2014
Q3
Hold
0
1875
2014
Q2
Hold
0
1835
2014
Q1
Hold
0
1802
2013
Q4
Hold
0
1898
2013
Q3
Hold
0
1840
2013
Q2
Hold
0
1795

Other funds holding PALI

Commonwealth Equity Services's PALI Position: Q2 2026 in Review

Commonwealth Equity Services sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 16,500 shares — an estimated $28.9K sold.

Commonwealth Equity Services first reported a position in PALI in Q4 2025 and held it in 2 quarters. The position peaked at $39.1K in Q4 2025. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Commonwealth Equity Services reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 16,500 Palisade Bio shares in Q2 2026, an estimated $28.9K.
  • Commonwealth Equity Services first reported a position in Palisade Bio in Q4 2025 and held it in 2 quarters.
  • Commonwealth Equity Services's Palisade Bio position peaked at $39.1K in Q4 2025.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.